GABY (OTCPK:GABL.F) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

GABL.F Stock Overview

GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States.

About the company

GABL.F fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Trading at 98.7% below our estimate of its fair value

Risk Analysis

Earnings have declined by 26.4% per year over past 5 years

Does not have a meaningful market cap ($4M)

Negative shareholders equity

Shares are highly illiquid

+ 1 more risk

GABY Inc. Competitors

SenesTech

NasdaqCM:SNES

US$2.6m

Akanda

NasdaqCM:AKAN

US$2.2m

Evoke Pharma

NasdaqCM:EVOK

US$4.7m

Resonate Blends

OTCPK:KOAN

US$562.2k

Price History & Performance

Summary of all time highs, changes and price drops for GABY
Historical stock prices
Current Share Price	CA$0.0014
52 Week High	CA$0.011
52 Week Low	CA$0.0004
Beta	1.03
11 Month Change	0%
3 Month Change	45.00%
1 Year Change	-61.84%
33 Year Change	-97.18%
5 Year Change	-99.61%
Change since IPO	-99.62%

Recent updates

Shareholder Returns

	GABL.F	US Pharmaceuticals	US Market
7D	0%	-4.8%	-0.8%
1Y	-61.8%	14.1%	31.5%

Return vs Industry: GABL.F underperformed the US Pharmaceuticals industry which returned -4.4% over the past year.

Return vs Market: GABL.F underperformed the US Market which returned 15.2% over the past year.

Price Volatility

Is GABL.F's price volatile compared to industry and market?
GABL.F volatility
GABL.F Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.4%
Market Average Movement	6.0%
10% most volatile stocks in US Market	15.1%
10% least volatile stocks in US Market	2.8%

Stable Share Price: GABL.F's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine GABL.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2003	n/a	n/a	www.gabyinc.com

GABY Inc., together with its subsidiaries, produces, markets, sells, and retails cannabis-related consumer packaged goods in the United States. The company packages and markets various cannabis products, including flowers, concentrates, pre-rolls, edibles, topicals, tinctures, and other products derived from or infused with cannabis or hemp. It offers its cannabis products under the Mankind, HempFusion, Sagely Naturals, Apothecanna, Kind Republic, Lulu’s, 2Rise, and Dank Space brand names.

GABY Inc. Fundamentals Summary

How do GABY's earnings and revenue compare to its market cap?
GABL.F fundamental statistics
Market cap	US$2.69m
Earnings (TTM)	-US$32.07m
Revenue (TTM)	US$20.73m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Is GABL.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GABL.F income statement (TTM)
Revenue	US$20.73m
Cost of Revenue	US$10.75m
Gross Profit	US$9.98m
Other Expenses	US$42.05m
Earnings	-US$32.07m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.043
Gross Margin	48.16%
Net Profit Margin	-154.72%
Debt/Equity Ratio	-106.8%

How did GABL.F perform over the long term?

See historical performance and comparison

GABY OTCPK:GABL.F Stock Report